Published on 5 Mar 2023 on Simply Wall St. via Yahoo Finance
Key Insights
Given the large stake in the stock by institutions, Pliant Therapeutics' stock price might be vulnerable to their trading decisions51% of the business is held by the top 12 shareholders Recent sales by insiders